Scientists behind 'golden rice' GM crop to receive humanitarian award from the White House

The rice could become a staple food that saves millions of lives

Biotechnologist Dr. Swapan Datta inspects a 'Golden Rice' plant at the International Rice Research Institute
Biotechnologist Dr. Swapan Datta inspects a 'Golden Rice' plant at the International Rice Research Institute

The scientists who invented vitamin-enriched “golden rice” will receive a humanitarian award tomorrow from the White House in Washington for developing a staple food that could save the lives of millions of people in the developing world.

Golden rice is genetically manipulated to turn on the genes for making beta-carotene, a nutritional precursor the body needs to manufacture its own vitamin A. These genes are switched off in ordinary white rice which can lead to severe vitamin A deficiency causing tens of millions of cases of blindness and death each year, mainly in South East Asia.

Environmental campaigners opposed to golden rice have organised the destruction of experimental field trials on the grounds that the GM rice represents a high-tech “quick fix” to vitamin A deficiency without addressing the underlying problems of poverty and poor nutrition.

“Genetically engineered ‘golden’ rice is environmentally irresponsible, poses risk to human health and could compromise food, nutrition and financial security,” said Greenpeace, which has led the opposition to the crop for the past two decades.

However, the White House Office of Science and Technology Policy and the US Patent and Trademark Office have awarded the inventors of golden rice the prestigious Patents for Humanity Award, which will be presented to Adrian Dubock, who as a former scientist at the agro-chemicals company Syngenta helped to arrange for the intellectual property behind the research to be made available free of charge to developing countries.

Dr Dubock, who will accept the award in Washington, shares the prize with its two co-inventors, Professor Ingo Potrykus of the Swiss Federal Institute of Technology in Zurich and Peter Beyer of the University of Freiburg in Germany, who granted Syngenta the rights to develop the technology. The company announced in 2004 that it had no continuing interest in the commercial exploitation of golden rice but would continue to support its development as a humanitarian project.

Vitamin A deficiency is a leading killer of children globally, accounting for between 2m and 3m deaths per year, as well as causing about 500,000 cases of blindness annually. White rice is the main daily staple crop for about 3.5bn people in the world, even though it is deficient in vitamin A, which is typically found in meat and leafy vegetables.

Supporters of golden rice said that it could have been introduced a decade ago but opposition by environmentalists has held up its regulatory approval, leading to the preventable death and blindness of tens of millions of people.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in